HAEMONETICS CORPORATION

Company

HAEMONETICS CORP

Filed

February 12, 2001

Accession Number

0000912938-01-000106

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →